Bristol Myers Squibb Unveils New Renewable Energy and Emissions Reduction Goals
Global biopharmaceutical company Bristol Myers Squibb announced today a series of new sustainability goals, including commitments to purchase 100% of the electricity the company uses from renewable sources by 2030, and to achieve Scope 1 and 2 carbon neutrality by 2040. Bristol Myers Squibb also set 2040 targets of equitable water use, zero waste to landfill and 100% electric vehicles in its fleet.
Danielle Menture, Bristol Myers Squibb Vice president of Sustainability, EHS and Occupational Health, said:
“As a leading global biopharma company dedicated to transforming patients’ lives through science, we understand our responsibility to create maximum positive impact while minimizing our environmental footprint. Now, after 20 years of setting global sustainability goals, we are honing our focus to continue to reduce our energy consumption and greenhouse gas (GHG) emissions, improve water use and reduce waste. Along with announcing these goals, we commit to increased transparency in reporting our progress to internal and external stakeholders.”
In addition to the new targets, Bristol Myers Squibb also announced a commitment to set approved science-based emissions reductions targets in alignment with the Science Based Targets initiative (SBTi).
Bristol Myers Squibb stated that its new goals are in line with the company’s strategy to leverage sustainability to drive innovation, build resiliency and manage non-financial risks across its operations and portfolio, and builds on announcements made earlier this year including a $300 million combined investment by Bristol Myers Squibb and the Bristol Myers Squibb Foundation in a series of commitments to Diversity & Inclusion and Health Equity.